The clinical experience of transnasal endoscopic approach for skull base osteoradionecrosis after radiotherapy for nasopharyngeal carcinoma.
- Author:
Guiping LAN
1
;
Bo HUANG
1
;
Yongfeng SI
1
;
Yangda QIN
1
;
Zhuoxia DENG
1
;
Yong YANG
1
;
Ying QIN
1
;
Benjian ZHANG
1
Author Information
- Publication Type:Journal Article
- MeSH: Carcinoma; Endoscopy; Humans; Nasopharyngeal Neoplasms; radiotherapy; Osteoradionecrosis; surgery; Retrospective Studies; Skull Base; surgery; Survival Rate
- From: Chinese Journal of Otorhinolaryngology Head and Neck Surgery 2016;51(5):367-371
- CountryChina
- Language:Chinese
-
Abstract:
OBJECTIVETo investigate the method of surgical treatment via trans-nasal endoscopic approach in osteoradionecrosis of skull base after radiotherapy for nasopharyngeal carcinoma.
METHODSFifteen patients with osteoradionecrosis of skull base after radiotherapy for nasopharyngeal carcinoma who underwent operation via trans-nasal endoscopic approach from 2008 to 2013 were retrospectively reviewed. The typical clinical manifestations included headache (NRS 6-9: 11 cases), foul odor (10 cases), epistaxis (4 cases), hearing loss (5 cases, 7 ears), tinnitus (4 cases, 5 ears). All patients underwent operation via trans-nasal endoscopic approach. During the operation, the diseased region was fully exposed, the necrotic tissue was resected, the necrotic bone was removed by high-speed electric drill, and the drainage was made unobstructed. The perioperative treatment and follow-up were carried out.
RESULTSAfter operation, all patients were diagnosed pathologically as osteoradionecrosis and mucosal chroinic inflammation, 1 case combined with fungal sphenoid sinusitis. Headache (9 cases) and foul odor (9 cases) resolved after operation. The follow-up was lasted 18-82 months, 13 cases were survival, 1 case lost to follow-up, 1 case died of cerebral hemorrhage.
CONCLUSIONSurgical treatment via trans-nasal endoscopic approach is safe and effective in osteoradionecrosis of skull base after radiotherapy for nasopharyngeal carcinoma, and is helping to improve the survival rate and survival quality.